Sezary disease is a rare type of cutaneous T-cell lymphoma characterized by erythroderma, lymphadenopathy, and circulating malignant T-cells. It is associated with significant morbidity and requires accurate diagnosis and documentation for effective management. The ICD-10 Code C84.18 facilitates precise coding for billing, clinical decision-making, and public health reporting, ensuring that healthcare providers can track and manage this complex condition appropriately.
ICD-10 Code C84.18 specifically denotes Sezary disease affecting lymph nodes at multiple sites. This condition is a leukemic form of cutaneous T-cell lymphoma, presenting with systemic symptoms and extensive skin involvement. The code is utilized in clinical documentation and billing when diagnosing patients with this specific malignancy, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
Sezary disease is a severe form of cutaneous T-cell lymphoma that manifests with widespread skin lesions, lymphadenopathy, and the presence of atypical T-cells in the blood. The etiology is linked to genetic mutations and environmental factors, leading to a progressive and often debilitating condition that necessitates prompt medical intervention.
In clinical workflows, ICD-10 Code C84.18 is essential for documenting the diagnosis of Sezary disease. It aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive care in both acute and chronic settings.
ICD-10 Code C84.18 connects subjective patient reports and objective clinical findings to a formal diagnosis of Sezary disease. This code is crucial for maintaining continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Sezary disease requires urgent medical attention, often necessitating hospitalization for management. Treatment may include systemic therapies tailored to the patient's condition.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.18 is critical for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99203 | Office or other outpatient visit for evaluation and management. |
| 96415 | Chemotherapy administration, intravenous, infusion technique. |
Common Questions About Using ICD-10 Code C84.18 for Sezary disease, lymph nodes of multiple sites
What are the common symptoms of Sezary disease?
Common symptoms include widespread erythroderma, lymphadenopathy, severe itching, and the presence of atypical T-cells in the blood. Patients may also experience fatigue and weight loss.
How is Sezary disease diagnosed?
Diagnosis is typically made through clinical evaluation, skin biopsy, and blood tests showing Sezary cells. Imaging studies may also be used to assess lymph node involvement.
What treatments are available for Sezary disease?
Treatment options include systemic therapies such as methotrexate, photopheresis, and supportive care to manage symptoms. Treatment plans are individualized based on disease severity.
Is Sezary disease contagious?
No, Sezary disease is not contagious. It is a malignancy of T-cells and does not spread from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes